Prodrugs for Amidines: Synthesis and Anti-<i>Pneumocystis carinii</i> Activity of Carbamates of 2,5-Bis(4-amidinophenyl)furan
作者:Syed M. Rahmathullah、James Edwin Hall、Brendan C. Bender、Donald R. McCurdy、Richard R. Tidwell、David W. Boykin
DOI:10.1021/jm990237+
日期:1999.9.1
Syntheses of several carbamate analogues of 2, 5-bis(4-amidinophenyl)furan (1) under mild conditions and their evaluation as prodrugs against Pneumocystis carinii pneumonia (PCP) in an immunosuppressed rat model are described. Thus, nine new bis-carbamates: methoxycarbonyl (2), 2,2,2-trichloroethoxycarbonyl (3), ethylthiocarbonyl (4), benzyloxycarbonyl (5), (4-methyl-2-oxo-1, 3-dioxol-4-en-5-yl)methoxycarbonyl
描述了在温和条件下2,5-双(4-ami基苯基)呋喃(1)的几种氨基甲酸酯类似物的合成及其在免疫抑制的大鼠模型中作为抗卡氏肺孢子虫肺炎(PCP)的前药的评估。因此,九种新的双氨基甲酸酯:甲氧羰基(2),2,2,2-三氯乙氧羰基(3),乙硫羰基(4),苄氧羰基(5),(4-甲基-2-氧代-1、3-二氧杂环戊-4 -en-5-基)甲氧基羰基(6),苯氧基羰基(7),4-氟苯氧基羰基(8),4-甲氧基苯氧基羰基(9)和(1-乙酰氧基)乙氧基羰基(10)和双碳酸酯乙氧基羰氧基(11)已经合成并评价了双am1的化合物。体内结果表明,该系列中的4-氟苯基氨基甲酸酯8和4-甲氧基苯基氨基甲酸酯9通过以22 mol和33 micromol / kg / day的剂量静脉内和口服给药均具有最佳的抗PCP活性,分别。口服给药时,化合物3-7的活性也比母体药物(1)高。通过前药修饰,母体am1在静脉内给药时通常